Table 1. Patient characteristics.

Characteristics	N=54	(%)
Median age	58.5 years
Range	(31.0–84.0)
<65	32	59.3
⩾65	22	40.7
Karnofsky performance status at baseline
70/80	11	20.4
90/100	43	79.6
Hormonal status
ER+/PR+	29	53.6
ER+/PR−	9	16.7
ER−/PR+	2	3.7
ER−/PR−	9	16.7
ER and/or PR unknown	5	9.3
Prior chemotherapy (early stage)	34	63.0
Type of Chemotherapy
Anthracycline-based without taxane	23	42.6
Anthracycline+taxane	6	11.1
CMF	5	9.3
Prior hormone therapy	41	75.9
For advanced disease	27	50.0
Number of metastatic sites
1	7	13.0
2	22	40.7
>2	25	46.3
Visceral involvement	42	77.8
Metastatic sites
Liver/lung metastases	26/25	48.1/46.3
Bone metastases	33	61.1
Skin/soft tissue	3/5	5.6/9.3
Median delay between diagnosis and first relapse	34.3 months